Everand Logo

Welcome to Everand!

  • STAT

    Listen: The future of CAR-T, an alarming cancer trend, and Sarepta’s FDA legacy

    Has CAR-T lost its luster? Why is colorectal cancer on the rise? And did the FDA forever change in 2016? Find out on the latest episode of "The Readout LOUD"…
    by Damian Garde and Rebecca Robbins and Adam Feuerstein Dec 12, 2019 1 minute

    Has CAR-T lost its luster? Why is colorectal cancer on the rise? And did the FDA forever change in 2016?

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
    New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
    And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
    STAT1 min readAmerican Government
    Opinion: As A Rule, Rape Exceptions For Abortion Don’t Work
    Abortion opponents often say they want to support survivors of rape. But abortion bans do the opposite, and no fake "rape exception" is going to change that.

    Related Books & Audiobooks